Sumitomo Mitsui Trust Holdings, Inc. Beam Therapeutics Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 4,266,871 shares of BEAM stock, worth $84.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,266,871
Previous 3,957,611
7.81%
Holding current value
$84.5 Million
Previous $98.1 Million
15.1%
% of portfolio
0.06%
Previous 0.07%
Shares
18 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.9MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$163 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$151 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$140 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$89.9 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.39B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...